INTRODUCTION
Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by the presence of chronic thromboembolic material in the pulmonary arteries [1] . Pulmonary endarterectomy (PEA) is the first line treatment in operable patients [2, 3] . Patients with a distal location of clots and those with persisting pulmonary hypertension after PEA can benefit from percutaneous balloon pulmonary angioplasty (BPA) [3] [4] [5] [6] [7] . Successful BPA procedures lead to relief of the right ventricle, whose normal function is an essential prognostic factor in patients with pulmonary hypertension [9] . Previous studies showed improvement in the right ventricular morphology and function after BPA as assessed with echocardiography [10, 11] . There is scarce data on electrocardiographic (ECG) changes in patients with CTEPH undergoing BPA [12] . The main aim of our study was to assess the correlations between the hemodynamic parameters of the pulmonary circulation and ECG parameters of the right ventricular hypertrophy (RVH) following BPA procedures to conduct a preliminary evaluation of the clinical usefulness of ECG in monitoring the efficacy of percutaneous interventional treatment of patients with CTEPH.
PATIENTS AND METHODS
The analysis was based on patients with CTEPH hospitalized at the European Health Centre in Otwock between 2013 and 2018. All the enrolled patients were diagnosed with CTEPH and were qualified for treatment with BPA in accordance with the current guidelines of the European Society of Cardiology for the diagnosis and treatment of pulmonary hypertension [13] . Out of 41 patients, 7 patients were diagnosed with persistent pulmonary hypertension following unsuccessful cardiosurgical treatment. The analysis did not include patients with coronary heart disease or significant cardiac arrhythmias, e.g. atrial fibrillation,
which made it difficult to analyze the electrocardiographic curve. The institutional ethics committee approved the study protocol, and informed consent was obtained from each patient before study (decision number 88/PB/2015).
Right heart catheterization and balloon pulmonary angioplasty
The right heart catheterization (RHC) was performed using the access via the internal jugular vein or femoral vein with the use of the Swan-Ganz catheter in accordance with current standards [14] . The following hemodynamic parameters were measured or calculated: mean right atrial pressure (RAP), mean and systolic pulmonary arterial pressure (mPAP and sPAP), pulmonary artery wedge pressure (PAWP), pulmonary vascular resistance (PVR), total pulmonary resistance (TPR), cardiac index (CI), stroke volume index (SVI), right ventricular stroke work index (RVSWI) and cardiac output (CO). Cardiac output (CO) was measured with the thermodilution method. The mean pulmonary arterial pressure in each patient was above 25 mmHg, and the wedge pressure was ≤ 15 mmHg.
The BPA procedures were conducted by two interventional cardiologists and an interventional radiologist experienced in percutaneous vascular procedures according to the previously described protocol [15] .
6-minute walk test and laboratory tests A 6-minute walking test (6MWT) was performed by qualified medical personnel in accordance with ATS (American Thoracic Society) guidelines [16] .
Myocardial necrosis was assessed with the measurement of highly sensitive troponin concentration with the use of the Elecsys Troponin T high sensitive assay (by Roche; plasma, N<0.003 ng/ml). Biochemical assessment of the degree of cardiac failure was performed with the measurement of NTproBNP (N-terminal pro-B-type natriuretic peptide) concentration with the use of the Elecsys NTproBNP assay (by Roche; serum, N<125 pg/ml).
Electrocardiogram
Standard 12-lead ECG was performed on each patient during calm breathing in the supine position with a commercially available ECG apparatus (Philips Page Writer TC 50).
Paper speed was 25 mm/s (1 mV=10 mm). The baseline ECG was performed one day before the first BPA and a control study was done at 3-6 months after the last BPA procedure ( Figure   1 ). The analysis included ECG signs of RVH, such as T wave axis (degrees); P wave amplitude II (uV); S wave amplitude V5 (uV); R:S wave ratio V5; R wave amplitude V6 (uV); QRS wave axis (degrees); RBBB (Right Bundle Branch Block); rSR' complex in lead V1 with R' > 10 mm (QRS < 120 ms); qR complex in lead V1; SIQIII pattern; R wave amplitude V1 + S wave amplitude V5/V6 > 10.5 mm; R wave amplitude aVR > 4 mm; R wave amplitude V1 > 6 mm; S wave amplitude V1 < 2 mm; ST-T segment depression by, at least, 1mm in a larger number of leads than from V1 to V3; ST-T segment depression by, at least, 1 mm in leads from V1 to V3; ST-T segment depression by, at least, 1 mm in leads: II, III, aVF; negative T wave in leads from V1 to V3; negative T wave in precordial leads in a larger number of leads than from V1 to V3; negative T wave in leads: II, III, aVF. The general characteristics of the population enrolled in the study are presented in Table 1 . 
STATISTICAL ANALYSIS

Statistical
ECG, hemodynamic and functional data after BPA in the entire study group
In the whole group of patients subject to interventional treatment, a comparison of hemodynamic, functional and electrocardiographic parameters was performed before and after BPA (Table 2 ).
1.4. ECG, hemodynamic and functional data in the subgroups regarding the efficacy of the BPA The whole analyzed group was divided into two subgroups regarding the efficacy of the interventional procedure defined as the percentage (%) decrease in the PVR against baseline: group A was defined as patients with a PVR decrease greater than the median value for the whole study population, i.e. patients with an excellent hemodynamic effect following interventional treatment, and group B was defined as patients with a PVR decrease lower than the median value for the whole study population, i.e. patients with a worse hemodynamic effect. The median value of PVR drop for the entire population was 49%.
In group A, there were statistically significant changes in the values of the ECG parameters of the RVH, as shown in Table 3 and Figure 3 . In group B, despite the observed hemodynamic and functional improvement following pulmonary angioplasty, none of the ECG parameters of the RVH found in group A was statistically significantly different.
DISCUSSION
The above results show a correlation between the improvement of the hemodynamic parameters of pulmonary circulation in CTEPH patients who underwent percutaneous treatment and resolution of specific ECG variables of the RVH.
Hemodynamic decompression of the right ventricle, leading to improvement of its function, is the important predictive factor for the survival of patients with pulmonary hypertension [17] .
Several previous studies showed that the regression of specific ECG signs of the right ventricular strain or RVH was observed in survivors of acute pulmonary embolism but also in patients with CTEPH after successful pulmonary endarterectomy and those with pulmonary arterial hypertension treated with specific pharmacotherapy [18] [19] [20] .
It has been shown that the presence of the qR complex in lead V1, R:S wave amplitude ratio in lead V1, and P wave amplitude in lead II had significant prognostic value in the population of patients with pulmonary hypertension, and some of them might be used to assess the efficacy of the therapy applied [18, [21] [22] [23] . It has been proved that the said presence of qR complex in lead V1 very well reflects the midsystolic dilation and flattening of the right ventricle and is an important predictor of mortality in the population of patients with pulmonary hypertension [23] . Therefore, the presence of qR complex was used in our analysis.
However, based on the correlations performed and the comparative analysis, no statistically significant difference was shown in the spreading of qR complex in lead V1 in CTEPH patients before and after BPA treatment.
Other studies also showed a close correlation between the P wave amplitude and the PVR value, which was significantly related to the change in the QRS complex axis [18] . The analysis of the changes in the above electrocardiographic values was aimed at assessing the response of patients with pulmonary hypertension to the applied form of therapy. In our studies, the change in the P wave amplitude in lead II was also significantly correlated with the change in PVR. Also, the QRS axis was significantly correlated with the change in the PVR and, as one of a few parameters, the change in the mPAP.
Previous studies also proved that the S wave amplitude in lead V1, the R:S amplitude ratio in lead V6, and the spreading of the SIQIII complex were significantly changed after the procedure of pulmonary endarterectomy, together with the observed reverse right ventricular remodeling assessed with the use of echocardiography [19] . It was also proved that the degree of the right ventricular size reduction was significantly correlated with the change in the cardiac axis and geometry observed on ECG examination [22, 24] . Nishiyama et al.'s study showed that the treatment of patients with CTEPH with the use of BPA caused the withdrawal of certain ECG signs of RVH, which is manifested as a significant improvement in the right ventricular systolic function. The ROC analysis in the above study confirmed, for example, that the value of the S wave amplitude in lead V5, sum of R wave amplitude in lead V1 and S wave in lead V5, S wave amplitude in lead I and QRS axis were important predictors of the mPAP ≥ 30 mmHg. Also, a significant correlation was observed with regard to the observed changes in the mPAP and in the values of the following electrocardiographic parameters: S wave in lead I, sum of amplitude of R wave in lead V1 and S wave in lead V5, as well as P wave amplitude in lead II [12] . The above study also showed that the R:S wave amplitude ratio in lead V1 ≥ 1 might be observed with a higher frequency in CTEPH patients whose hemodynamic parameters were improved following treatment with BPA [12] .
Our study also confirmed the clinical significance of the amplitude of R and S waves of lead V5 in the assessment of reverse ECG right ventricular remodeling. Concerning P wave, its assessment was significant not only in lead II but also in lead III. Both previous studies and the present study confirmed the statistical significance of S wave in lead I, whose amplitude change in our study was significantly correlated with the change in the PVR and mPAP.
In patients with CTEPH, RBBB associated with RVH is usually related to right ventricle enlargement and a lengthening of the conduction pathway. It should be kept in mind that the size of the right ventricle cavity may be subject to certain dynamics. Therefore, even hemodynamically effective BPA may not cause resolution of RBBB. Nevertheless, the differences before and after BPA procedures for the occurrence of RBBB were statistically insignificant both in the whole group and subgroups with good and moderate hemodynamic 
